Bayer Aktiengesellschaft (BAYZF)
| Market Cap | 24.40B |
| Revenue (ttm) | 50.34B |
| Net Income (ttm) | -3.52B |
| Shares Out | n/a |
| EPS (ttm) | -3.58 |
| PE Ratio | n/a |
| Forward PE | 4.82 |
| Dividend | 0.13 (0.45%) |
| Ex-Dividend Date | Apr 28, 2025 |
| Volume | 10,300 |
| Average Volume | 3,605 |
| Open | 27.92 |
| Previous Close | 26.79 |
| Day's Range | 27.77 - 27.97 |
| 52-Week Range | 19.50 - 34.01 |
| Beta | 0.98 |
| RSI | 64.68 |
| Earnings Date | May 13, 2025 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]
Financial Performance
In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.
Financial numbers in EUR Financial StatementsNews
Bayer: U.S. Supreme Court could decide in June whether it will hear glyphosate case
Bayer said on Tuesday that the U.S. Supreme Court could decide as early as next month whether it will hear the German company's request to sharply limit litigation that could run into the billions of ...
Bayer shares soar as company records strong cancer drug demand
Bayer’s strong first quarter performance was mainly driven by its pharmaceuticals division, even as its crop-science branch lagged.
Bayer Shares Jump After Results Beat Expectations on Pharma Strength
Bayer posts smaller than expected 7.4% drop in quarterly adjusted profit
Bayer on Tuesday posted a slower decline in first-quarter adjusted earnings than the market had feared as strong prescription numbers for new drugs offset a drop in its soy and cotton seed business.
Bayer AG Non-GAAP EPS of €2.49, revenue of €13.74B; updates FY25 outlook
Second US state moves to shield Bayer from Roundup claims
In a victory for global agrochemical maker Bayer, Georgia has become the second US state to shield pesticide manufacturers from some lawsuits claiming that they failed to warn customers of potential d...
Georgia’s governor is shielding Roundup weed killer’s maker from cancer warning lawsuits
Bayer has stopped using the ingredient in its residential version of Roundup and has set aside $16 billion to settle cases.
Bayer to overhaul Crop Science division, cutting hundreds of jobs
Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices
Scott Gottlieb, former FDA commissioner, joins CNBC's 'Squawk on the Street' to discuss how the White House may plan to cut drug prices.
Bayer to Slash Hundreds of Jobs in Crop Division Overhaul
The company said it will discontinue certain production activities at its Dormagen and Frankfurt am Main sites.
Bayer U.S. Surveys Shed Further Light on the Diversity of Menopause Care Approaches and Menopause Symptom Experiences
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer U.S. Surveys Shed Further Light on the Diversity of Menopause Care Approaches and Menopause Symptom Experiences.
Don't Let Corn Rootworm Steal Your Yield: Bayer Launches The Watch 2025
ST. LOUIS--(BUSINESS WIRE)--Corn rootworm remains one of the most damaging pests in U.S. corn production, causing an estimated $1 billion in losses each year. To help farmers get ahead of this undergr...
Plaintiffs' Attorneys Respond to Bayer's Threat to Pull Roundup from Market
DALLAS--(BUSINESS WIRE)--Attorneys representing thousands of cancer victims criticized Bayer today for what they describe as an attempt to pressure courts, lawmakers and the public by threatening to p...
Bayer Initiates Phase I Study Targeting GPC3 With Actinium-225 Radiopharmaceutical in Patients With Advanced Hepatocellular Carcinoma
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being developed to tr...
Guru Ramamurthy Appointed as New CFO for Bayer's Crop Science Division
MONHEIM, Germany--(BUSINESS WIRE)--Bayer announced today that Guru Ramamurthy will become the new Chief Financial Officer (CFO) for Bayer's Crop Science division. He will succeed Oliver Rittgen who ha...
North Dakota governor signs measure protecting pesticide makers from lawsuits
North Dakota has become the first state in the country to protect farm chemical manufacturers, including Bayer, from lawsuits over the safety of their products, such as the weedkiller Roundup.
World Bank adds Bayer, Hyatt and other CEOs to private sector initiative
The World Bank on Wednesday added four top executives, including Bayer AG CEO Bill Anderson and Hyatt Hotels CEO Mark Hoplamazian, to an initiative working to address barriers to private sector invest...
ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ -- powered by Guardant Health liquid biopsy genomic data -- and AI Sa...
ConcertAI Announce Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ -- powered by Guardant Health liquid biopsy genomic data -- and AI Sa...
CEO do Bayer revela 'acordo de cavalheiros' para liberar Xabi, alvo do Real
CEO do Bayer revela 'acordo de cavalheiros' para liberar Xabi Alonso, alvo do Real
Bayer CEO: targeting US state regulation to stem glyphosate costs
Bayer is lobbying U.S. states to adjust their regulatory framework in its battle to wind down costly litigation over its weedkiller glyphosate, the German chemicals company's CEO said in a draft speec...
Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community
MYERSTOWN, Pa.--(BUSINESS WIRE)--Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This s...
Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting.
Bayer is said to consider ending production of Roundup amid legal costs
Farmers' Favorite Weedkiller Nears Its End, Bayer Warns
The German company cites mounting costs from lawsuits blaming Roundup for causing cancer.